Announcements

4 February 2024
Acknowledgment of the Reviewers of Nutraceuticals in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Nutraceuticals. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Nutraceuticals received 164 review reports, from 150 reviewers. This past year, we worked with reviewers from 42 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Nutraceuticals family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

Abdullah Hussain Jiraporn Leanpolchareanchai
Agnes Farkas Jose E. Aguilar-Toala
Agnieszka Rudzka Karen Ildico Hirsch-Ernst
Agnieszka Zelek-Molik Marek Wesolowski
Ahmed Mediani Maria Lopes
Alejandro Gonzalez-Candia Mohammed Sikander
Alessia Mariano Mohind Mohan
Arulselvan Palanisamy Muni Swamy Ganjayi
Atheer Zgair Natalia Piekuś-Słomka
Avinash Kundadka Kudva Nazir Ahmad
Ayman Mahmoud Noura Dosoky
Bilal Ghalloo Nurpudji Astuti Taslim
Concepción Obon Pankaj Singh
Constantinos Giaginis Philip Chilibeck
Damiano Spagnuolo Pinaki Bhattacharjee
Dan Razvan Popoviciu Qi Xiang
Daryoush Babazadeh Ravi Vumma
Dasha Mihaylova Roberto Cannataro
Dedi Noviendri Sandro Jose Ribeiro Bonatto
Deepika Singh Shabbir Hussain
Elisa Belluzzi Sharangouda Patil
Elzbieta Wierzbicka Silvia P. Tsanova-Savova
Espérance Debs Siyamak Safapour
Fatemeh Ghiasi Snigdha Guha
Gizem Emre Sonia Singh
Gjylije Hoti Syed Amir Ashraf
Guillermo Cásedas Tamás Hofmann
Hala Zaatout Tobias Fischer
Haniza Hassan Vijayaraj Radha
Hany H. Arab Vira Lubenets
Hsinjung Ho Xiuli Li
Hunter Waldman Yesi Desmiaty
Insha Sultan Yingqian Chen
Ioana-Mirela Vasincu Yuefan Song
Jinle Xiang Zhibin Liu

More News...
Back to TopTop